• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物活性化合物自动从头设计的生成式和强化学习方法。

Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds.

作者信息

Korshunova Maria, Huang Niles, Capuzzi Stephen, Radchenko Dmytro S, Savych Olena, Moroz Yuriy S, Wells Carrow I, Willson Timothy M, Tropsha Alexander, Isayev Olexandr

机构信息

Department of Chemistry, Mellon College of Science, Carnegie Mellon University, Pittsburgh, PA, USA.

Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, USA.

出版信息

Commun Chem. 2022 Oct 18;5(1):129. doi: 10.1038/s42004-022-00733-0.

DOI:10.1038/s42004-022-00733-0
PMID:36697952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9814657/
Abstract

Deep generative neural networks have been used increasingly in computational chemistry for de novo design of molecules with desired properties. Many deep learning approaches employ reinforcement learning for optimizing the target properties of the generated molecules. However, the success of this approach is often hampered by the problem of sparse rewards as the majority of the generated molecules are expectedly predicted as inactives. We propose several technical innovations to address this problem and improve the balance between exploration and exploitation modes in reinforcement learning. In a proof-of-concept study, we demonstrate the application of the deep generative recurrent neural network architecture enhanced by several proposed technical tricks to design inhibitors of the epidermal growth factor (EGFR) and further experimentally validate their potency. The proposed technical solutions are expected to substantially improve the success rate of finding novel bioactive compounds for specific biological targets using generative and reinforcement learning approaches.

摘要

深度生成神经网络在计算化学中越来越多地用于从头设计具有所需特性的分子。许多深度学习方法采用强化学习来优化所生成分子的目标特性。然而,这种方法的成功往往受到稀疏奖励问题的阻碍,因为预计大多数生成的分子会被预测为无活性。我们提出了几种技术创新来解决这个问题,并改善强化学习中探索和利用模式之间的平衡。在一项概念验证研究中,我们展示了通过几种提出的技术技巧增强的深度生成循环神经网络架构在设计表皮生长因子(EGFR)抑制剂方面的应用,并进一步通过实验验证了它们的效力。预计所提出的技术解决方案将大幅提高使用生成式和强化学习方法寻找针对特定生物靶点的新型生物活性化合物的成功率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/e2c2002de65c/42004_2022_733_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/10902c51192e/42004_2022_733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/7bcd73d082b0/42004_2022_733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/9e814563da37/42004_2022_733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/7e71d53009ff/42004_2022_733_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/e2c2002de65c/42004_2022_733_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/10902c51192e/42004_2022_733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/7bcd73d082b0/42004_2022_733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/9e814563da37/42004_2022_733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/7e71d53009ff/42004_2022_733_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/476d/9814657/e2c2002de65c/42004_2022_733_Fig5_HTML.jpg

相似文献

1
Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds.用于生物活性化合物自动从头设计的生成式和强化学习方法。
Commun Chem. 2022 Oct 18;5(1):129. doi: 10.1038/s42004-022-00733-0.
2
Deep reinforcement learning for de novo drug design.基于深度强化学习的从头药物设计。
Sci Adv. 2018 Jul 25;4(7):eaap7885. doi: 10.1126/sciadv.aap7885. eCollection 2018 Jul.
3
LOGICS: Learning optimal generative distribution for designing de novo chemical structures.LOGICS:学习用于设计全新化学结构的最优生成分布。
J Cheminform. 2023 Sep 7;15(1):77. doi: 10.1186/s13321-023-00747-3.
4
Generative Deep Learning for Targeted Compound Design.生成式深度学习在靶向化合物设计中的应用。
J Chem Inf Model. 2021 Nov 22;61(11):5343-5361. doi: 10.1021/acs.jcim.0c01496. Epub 2021 Oct 26.
5
MoleGuLAR: Molecule Generation Using Reinforcement Learning with Alternating Rewards.MoleGuLAR:使用交替奖励的强化学习进行分子生成。
J Chem Inf Model. 2021 Dec 27;61(12):5815-5826. doi: 10.1021/acs.jcim.1c01341. Epub 2021 Dec 6.
6
De novo generation of dual-target ligands using adversarial training and reinforcement learning.使用对抗训练和强化学习生成双靶配体。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab333.
7
Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models.基于图的深度生成模型的强化学习药物设计。
J Chem Inf Model. 2022 Oct 24;62(20):4863-4872. doi: 10.1021/acs.jcim.2c00838. Epub 2022 Oct 11.
8
Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.深度生成模型中基于结构和配体的评分函数比较:以G蛋白偶联受体为例的研究
J Cheminform. 2021 May 13;13(1):39. doi: 10.1186/s13321-021-00516-0.
9
Generative Adversarial Networks for De Novo Molecular Design.生成对抗网络用于从头分子设计。
Mol Inform. 2021 Oct;40(10):e2100045. doi: 10.1002/minf.202100045. Epub 2021 Jul 6.
10
Molecular de-novo design through deep reinforcement learning.通过深度强化学习进行分子从头设计。
J Cheminform. 2017 Sep 4;9(1):48. doi: 10.1186/s13321-017-0235-x.

引用本文的文献

1
Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects.在激酶抑制剂开发中利用人工智能和机器学习:进展、挑战及未来前景。
RSC Med Chem. 2025 Aug 12. doi: 10.1039/d5md00494b.
2
Machine Learning and Artificial Intelligence in Nanomedicine.纳米医学中的机器学习与人工智能
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jul-Aug;17(4):e70027. doi: 10.1002/wnan.70027.
3
Optimizing drug design by merging generative AI with a physics-based active learning framework.

本文引用的文献

1
Scaffold-based molecular design with a graph generative model.基于支架的分子设计与图形生成模型。
Chem Sci. 2019 Dec 3;11(4):1153-1164. doi: 10.1039/c9sc04503a.
2
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification.激酶化学基因组集(KCGS):用于鉴定激酶易损性的开放科学资源。
Int J Mol Sci. 2021 Jan 8;22(2):566. doi: 10.3390/ijms22020566.
3
OpenChem: A Deep Learning Toolkit for Computational Chemistry and Drug Design.OpenChem:一个用于计算化学和药物设计的深度学习工具包。
通过将生成式人工智能与基于物理学的主动学习框架相结合来优化药物设计。
Commun Chem. 2025 Aug 8;8(1):238. doi: 10.1038/s42004-025-01635-7.
4
Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey.用于从头药物设计的生成式深度学习——一场化学空间奥德赛。
J Chem Inf Model. 2025 Jul 28;65(14):7352-7372. doi: 10.1021/acs.jcim.5c00641. Epub 2025 Jul 9.
5
PLASMOpred: A Machine Learning-Based Web Application for Predicting Antimalarial Small Molecules Targeting the Apical Membrane Antigen 1-Rhoptry Neck Protein 2 Invasion Complex.PLASMOpred:一种基于机器学习的网络应用程序,用于预测靶向顶端膜抗原1-棒状体颈部蛋白2入侵复合物的抗疟小分子。
Pharmaceuticals (Basel). 2025 May 23;18(6):776. doi: 10.3390/ph18060776.
6
Scaffold Hopping with Generative Reinforcement Learning.基于生成式强化学习的支架跳跃
J Chem Inf Model. 2025 Jul 14;65(13):6513-6525. doi: 10.1021/acs.jcim.5c00029. Epub 2025 Jun 26.
7
From Patterns to Pills: How Informatics Is Shaping Medicinal Chemistry.从模式到药丸:信息学如何塑造药物化学
Pharmaceutics. 2025 May 5;17(5):612. doi: 10.3390/pharmaceutics17050612.
8
Hybridization of SMILES and chemical-environment-aware tokens to improve performance of molecular structure generation.将SMILES与化学环境感知令牌进行杂交以提高分子结构生成的性能。
Sci Rep. 2025 May 15;15(1):16892. doi: 10.1038/s41598-025-01890-7.
9
ICVAE: Interpretable Conditional Variational Autoencoder for De Novo Molecular Design.ICVAE:用于从头分子设计的可解释条件变分自编码器。
Int J Mol Sci. 2025 Apr 23;26(9):3980. doi: 10.3390/ijms26093980.
10
Cross-disciplinary perspectives on the potential for artificial intelligence across chemistry.关于人工智能在化学领域潜力的跨学科观点。
Chem Soc Rev. 2025 Apr 25. doi: 10.1039/d5cs00146c.
J Chem Inf Model. 2021 Jan 25;61(1):7-13. doi: 10.1021/acs.jcim.0c00971. Epub 2021 Jan 4.
4
Memory-assisted reinforcement learning for diverse molecular de novo design.用于多样分子从头设计的记忆辅助强化学习
J Cheminform. 2020 Nov 10;12(1):68. doi: 10.1186/s13321-020-00473-0.
5
Generating Multibillion Chemical Space of Readily Accessible Screening Compounds.生成易于获取的筛选化合物的数十亿化学空间。
iScience. 2020 Oct 15;23(11):101681. doi: 10.1016/j.isci.2020.101681. eCollection 2020 Nov 20.
6
Rethinking drug design in the artificial intelligence era.人工智能时代的药物设计再思考。
Nat Rev Drug Discov. 2020 May;19(5):353-364. doi: 10.1038/s41573-019-0050-3. Epub 2019 Dec 4.
7
Deep learning enables rapid identification of potent DDR1 kinase inhibitors.深度学习可快速鉴定有效的 DDR1 激酶抑制剂。
Nat Biotechnol. 2019 Sep;37(9):1038-1040. doi: 10.1038/s41587-019-0224-x. Epub 2019 Sep 2.
8
GuacaMol: Benchmarking Models for de Novo Molecular Design.GuacaMol:从头设计分子的模型基准测试。
J Chem Inf Model. 2019 Mar 25;59(3):1096-1108. doi: 10.1021/acs.jcim.8b00839. Epub 2019 Mar 19.
9
ChEMBL: towards direct deposition of bioassay data.ChEMBL:致力于直接生成生物测定数据。
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940. doi: 10.1093/nar/gky1075.
10
Deep reinforcement learning for de novo drug design.基于深度强化学习的从头药物设计。
Sci Adv. 2018 Jul 25;4(7):eaap7885. doi: 10.1126/sciadv.aap7885. eCollection 2018 Jul.